Skip to main content
Clinical Trials/NCT05795166
NCT05795166
Completed
Not Applicable

A Multicentre, Observational Study to Understand the Distribution of Obesity Classes and Obesity Related Comorbidities (ORCs) in People With Obesity Within a Real World Population in Czech Republic, Hungary and Poland

Novo Nordisk A/S0 sites1,241 target enrollmentApril 27, 2023
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Novo Nordisk A/S
Enrollment
1241
Primary Endpoint
Percentage of patients with at least one obesity related comorbidity of interest for obesity classes I, II and III pooled across all countries
Status
Completed
Last Updated
last year

Overview

Brief Summary

The study is intended to understand the distribution of different obesity classes and obesity related diseases (diseases that present along with obesity) in patients with body mass index (BMI) ≥ 30 kg/m^2.

Participants will be asked to give information about their health. They will continue their normal way of life and will not get any medication or additional medical test other than those prescribed to you by their doctor. Participation in the study will last for about 1 day.

Registry
clinicaltrials.gov
Start Date
April 27, 2023
End Date
November 30, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age greater than or equal to 18 years at the time of inclusion/enrolment in the study.
  • BMI greater than or equal to 30 Kg/m\^2 as measured at the inclusion in the study

Exclusion Criteria

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation as judged by physician.

Outcomes

Primary Outcomes

Percentage of patients with at least one obesity related comorbidity of interest for obesity classes I, II and III pooled across all countries

Time Frame: At the time of enrolment (Day 1)

% patients with obesity

Similar Trials